<DOC>
	<DOC>NCT00989729</DOC>
	<brief_summary>The purpose of this study is to attenuate the systemic inflammatory response after Endovascular repair of abdominal aortic aneurysms, by administration of a single preoperative dosage of Methylprednisolone.</brief_summary>
	<brief_title>Preoperative Methylprednisolone in Endovascular Aortic Repair</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Elective endovascular repair of an asymptomatic abdominal aortic aneurysm. Informed signed consent Positive HIV status, positive hepatitis B or C status Immunoinflammatory disease except topically treated skin disease and respiratory disease. Glaucoma Gastric or duodenal ulcer Systemic fungal infection Immunosuppressive treatment Current treatment for cancer Allergy towards contents of SoluMedrol Alcohol consumption: Men &gt; 21 drinks and women &gt; 14 drinks weekly Pregnancy Lack of informed signed consent Patients where follow up is planned at other location than Rigshospitalet.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Endovascular Aortic Repair</keyword>
	<keyword>Methylprednisolone</keyword>
	<keyword>Systemic inflammatory response syndrome</keyword>
</DOC>